Australian Ethics Committee Approval to Expand PD-L1 Nanobody (RAD204) Phase 1 Trial in Multiple Tumor Types

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce it has been granted Human Research Ethics Committee (HREC) approval to include participants with Programmed Death-Ligand 1 (PD-L1) positive Small Cell Lung Cancer (SCLC), Triple Negative Breast…

Read More

How to Invest in Chromium Stocks (Updated 2024)

Chromium is a metal for the modern age with a bright future. It is one of the more durable metals available, and is an integral component of stainless steel, which is used in infrastructure and machinery and supports construction activity around the world. The United States Geological Survey (USGS) estimates that most stainless steel contains…

Read More

S&P 500 Futures Slip 0.51%

U.S. stock futures dropped early Friday as the postelection rally showed signs of faltering and the Federal Reserve indicated a cautious stance on further interest rate cuts. Dow Jones Industrial Average futures fell 156 points, or 0.36%, while S&P 500 and Nasdaq 100 futures declined 0.51% and 0.76%, respectively. Tech stocks saw mixed fortunes, with…

Read More

PamBoRich and OpenAI: New Era of AI-Powered Trading Systems

In the fast-paced world of cryptocurrency trading, having a strategic edge is essential for investors aiming to navigate the volatile markets. PamBoRich, a rising star in the financial sector, is known for its innovative approach to automated trading solutions. With a reputation for cutting-edge technology and unmatched efficiency, PamBoRich has become a trusted platform for…

Read More